Technology-Driven Diabetes Care: Real-World Evidence from 3790 People with Diabetes on Improved Glycemic Management while Using a Mobile Diabetes App

Background: Technology-enabled diabetes self-management solutions may positively affect clinical outcomes in people with diabetes (PWD). This real-world study demonstrates improvement of glycemic metrics in individuals using a diabetes app with a family of Bluetooth® connected blood glucose (BG) meters. Methods: Aggregated anonymized BG readings extracted from the app server were analyzed from 3790 PWD divided into two groups based on when they started using the app and meter: PWD who started using the meter, installed the app, and synchronized on the same day (Group 1), and PWD who had used the meter for ≥14 days before they installed the app and performed syncing (Group 2). For Group 1, data from the first 14-days using meter and app (baseline) were compared with 14-days prior to 90- and 180-days using paired, within-subject differences. For Group 2, we additionally used data from the 14 days prior to app installation as pre-baseline. Results: In Group 1, people with type 1 diabetes (T1D) and type 2 diabetes (T2D) reduced mean BG by −7.8 and −18.3 mg/dL, respectively, improving readings in range (RIR) by +3.4 (68.6%–72.0%) and +10.6 percentage points (80.8%–91.4%), respectively, from baseline to 180 days. In Group 2, people with T1D and T2D reduced mean BG by −13.5 and −13.3 mg/dL, respectively, from pre-baseline to baseline and by −11.6 and −22.9 mg/dL from pre-baseline to 180 days. RIR improved by +5.1 (58.3%–63.4%) and +12.4 percentage points (73.9%–86.4%) in people with T1D and T2D, respectively, from pre-baseline to 180 days, with people with T1D showing the most pronounced improvement in the first 2 weeks of app usage (+7.4 percentage points, 58.3%–65.6%). All glycemic changes were statistically significant ( P < 0.01). Conclusion: Real-world data demonstrated improvements in glycemic metrics among 3790 PWDs using a mobile app with a connected glucose meter.

Institutions

Publication Details

Journal
Diabetes Technology and Obesity Medicine
Published
2025-10-01
DOI
https://doi.org/10.1177/29986702251404881
Primary Topic
Mobile Health and mHealth Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Technology-Driven Diabetes Care: Real-World Evidence from 3790 People with Diabetes on Improved Glycemic Management while Using a Mobile Diabetes App

Diabetes Technology and Obesity Medicine
Mobile Health and mHealth Applications
article

Technology-Driven Diabetes Care: Real-World Evidence from 3790 People with Diabetes on Improved Glycemic Management while Using a Mobile Diabetes App

article en

Abstract

Background: Technology-enabled diabetes self-management solutions may positively affect clinical outcomes in people with diabetes (PWD). This real-world study demonstrates improvement of glycemic metrics in individuals using a diabetes app with a family of Bluetooth® connected blood glucose (BG) meters. Methods: Aggregated anonymized BG readings extracted from the app server were analyzed from 3790 PWD divided into two groups based on when they started using the app and meter: PWD who started using the meter, installed the app, and synchronized on the same day (Group 1), and PWD who had used the meter for ≥14 days before they installed the app and performed syncing (Group 2). For Group 1, data from the first 14-days using meter and app (baseline) were compared with 14-days prior to 90- and 180-days using paired, within-subject differences. For Group 2, we additionally used data from the 14 days prior to app installation as pre-baseline. Results: In Group 1, people with type 1 diabetes (T1D) and type 2 diabetes (T2D) reduced mean BG by −7.8 and −18.3 mg/dL, respectively, improving readings in range (RIR) by +3.4 (68.6%–72.0%) and +10.6 percentage points (80.8%–91.4%), respectively, from baseline to 180 days. In Group 2, people with T1D and T2D reduced mean BG by −13.5 and −13.3 mg/dL, respectively, from pre-baseline to baseline and by −11.6 and −22.9 mg/dL from pre-baseline to 180 days. RIR improved by +5.1 (58.3%–63.4%) and +12.4 percentage points (73.9%–86.4%) in people with T1D and T2D, respectively, from pre-baseline to 180 days, with people with T1D showing the most pronounced improvement in the first 2 weeks of app usage (+7.4 percentage points, 58.3%–65.6%). All glycemic changes were statistically significant ( P < 0.01). Conclusion: Real-world data demonstrated improvements in glycemic metrics among 3790 PWDs using a mobile app with a connected glucose meter.

Diabetes Technology and Obesity MedicineVol. 1(1)
Endocrinology Research Center (RU), Reaction Biology Corporation (United States) (US), Academy of the Federal Security Service of the Russian Federation (RU)
Openalex Percentile: Top 28%
Mobile Health and mHealth Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.